Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Biomarin Pharmaceutical Inc Share Price

BMRN

NSQ

$59.87

-$0.07

(-0.12%)

Industry: Biotechnology Sector: Health Care

Biomarin Pharmaceutical Inc Analyst Forecast

Overview Returns Financials Ratios News FAQs

Biomarin Pharmaceutical Inc Share Price Chart

Biomarin Pharmaceutical Inc Key Stock Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

$11.52B

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

22.2825

Volume

This is the total number of shares traded during the most recent trading day.

1.94M

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

0.26

52-week Range info-icon

This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$50.76 L

$73.51 H

$59.87

About Biomarin Pharmaceutical Inc, Common Stock

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NAGLAZYME, a recombinant form of N- acetylgalactosamine 4-sulfatase for patients with MPS VI; and PALYNZIQ, a PEGylated recombinant phenylalanine (Phe) ammonia lyase enzyme delivered through subcutaneous injection to reduce blood Phe concentrations. It also develops BRINEURA, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; ALDURAZYME, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase; KUVAN, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria, an inherited metabolic disease; and ROCTAVIAN, an adeno associated virus vector for the treatment of severe hemophilia A. The company's products under development include BMN 333, a longer-acting CNP for the treatment of multiple growth disorders, such as achondroplasia and hypochondroplasia; BMN 349, an oral therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency; and BMN 351, an oligonucleotide for the treatment of duchenne muscular dystrophy. It serves specialty pharmacies, hospitals, non-U.S. government agencies, distributors, and pharmaceutical wholesalers. The company has license and collaboration agreements with Catalyst Pharmaceutical Partners, Inc., and Ares Trading S.A. The company was incorporated in 1996 and is based in San Rafael, California. more

Industry: BiotechnologySector: Health Care

Biomarin Pharmaceutical Inc Stock Returns

Time Frame	BMRN	Sector	S&P500
1-Week Return	3.11%	-1.08%	-1.38%
1-Month Return	8.59%	-0.47%	-1.81%
3-Month Return	10.55%	2.13%	1.38%
6-Month Return	2.81%	17.04%	5.68%
1-Year Return	-6.95%	6.56%	11.74%
3-Year Return	-45.01%	16.78%	65.15%
5-Year Return	-29.43%	34.34%	73.68%
10-Year Return	-19.28%	137.88%	260.03%

Time Frame	BMRN	Sector	S&P500
1-Week Return	393.79%	-43.23%	-51.55%
1-Month Return	172.55%	-5.57%	-19.93%
3-Month Return	50.19%	8.92%	5.72%
6-Month Return	5.78%	37.58%	11.85%
1-Year Return	-6.95%	6.56%	11.74%
3-Year Return	-18.07%	5.31%	18.20%
5-Year Return	-6.73%	6.08%	11.67%
10-Year Return	-2.12%	9.05%	13.67%

Biomarin Pharmaceutical Inc Financials

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Total Revenue	1.85B	2.10B	2.42B	2.85B	-	[{"date":"2021-12-31","value":64.69,"profit":true},{"date":"2022-12-31","value":73.44,"profit":true},{"date":"2023-12-31","value":84.77,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Cost of Revenue	470.51M	503.02M	532.06M	580.24M	-	[{"date":"2021-12-31","value":81.09,"profit":true},{"date":"2022-12-31","value":86.69,"profit":true},{"date":"2023-12-31","value":91.7,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Profit	1.38B	1.59B	1.89B	2.27B	-	[{"date":"2021-12-31","value":60.51,"profit":true},{"date":"2022-12-31","value":70.06,"profit":true},{"date":"2023-12-31","value":83,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Margin	74.52%	76.00%	78.01%	79.67%	-	[{"date":"2021-12-31","value":93.53,"profit":true},{"date":"2022-12-31","value":95.4,"profit":true},{"date":"2023-12-31","value":97.91,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Operating Expenses	1.46B	1.43B	1.70B	1.79B	-	[{"date":"2021-12-31","value":81.48,"profit":true},{"date":"2022-12-31","value":80.03,"profit":true},{"date":"2023-12-31","value":95.08,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Operating Income	(82.34M)	160.97M	185.77M	484.21M	-	[{"date":"2021-12-31","value":-17.01,"profit":false},{"date":"2022-12-31","value":33.24,"profit":true},{"date":"2023-12-31","value":38.37,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Non-Operating Income/Expense	2.14M	(9.33M)	36.93M	119.70M	-	[{"date":"2021-12-31","value":1.78,"profit":true},{"date":"2022-12-31","value":-7.8,"profit":false},{"date":"2023-12-31","value":30.85,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Pre-Tax Income	(75.35M)	149.58M	188.56M	541.76M	26.79M	[{"date":"2021-12-31","value":-13.91,"profit":false},{"date":"2022-12-31","value":27.61,"profit":true},{"date":"2023-12-31","value":34.81,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":4.94,"profit":true}]
Income Taxes	(11.27M)	8.02M	20.92M	114.90M	-	[{"date":"2021-12-31","value":-9.81,"profit":false},{"date":"2022-12-31","value":6.98,"profit":true},{"date":"2023-12-31","value":18.2,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income After Taxes	(64.08M)	141.56M	167.65M	426.86M	-	[{"date":"2021-12-31","value":-15.01,"profit":false},{"date":"2022-12-31","value":33.16,"profit":true},{"date":"2023-12-31","value":39.27,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Income From Continuous Operations	(64.08M)	141.56M	147.02M	426.86M	-	[{"date":"2021-12-31","value":-15.01,"profit":false},{"date":"2022-12-31","value":33.16,"profit":true},{"date":"2023-12-31","value":34.44,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	(64.08M)	141.56M	167.65M	426.86M	26.79M	[{"date":"2021-12-31","value":-15.01,"profit":false},{"date":"2022-12-31","value":33.16,"profit":true},{"date":"2023-12-31","value":39.27,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":6.27,"profit":true}]

EPS (Diluted)	(0.36)	0.29	0.95	2.49	2.69	[{"date":"2021-12-31","value":-13.38,"profit":false},{"date":"2022-12-31","value":10.73,"profit":true},{"date":"2023-12-31","value":35.32,"profit":true},{"date":"2024-12-31","value":92.57,"profit":true},{"date":"2025-12-31","value":100,"profit":true}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Total Revenue	-	13.53%	15.42%	17.97%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":75.29,"profit":true},{"date":"2023-12-31","value":85.81,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Cost of Revenue	-	6.91%	5.77%	9.05%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":76.31,"profit":true},{"date":"2023-12-31","value":63.76,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Profit	-	15.79%	18.46%	20.48%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":77.1,"profit":true},{"date":"2023-12-31","value":90.15,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Gross Margin	-	1.99%	2.64%	2.13%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":75.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":80.73,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Operating Expenses	-	(1.79%)	18.81%	5.18%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-9.5,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":27.52,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Operating Income	-	(295.50%)	15.41%	160.65%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-183.94,"profit":false},{"date":"2023-12-31","value":9.59,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Non-Operating Income/Expense	-	(536.99%)	(495.66%)	224.12%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-239.59,"profit":false},{"date":"2023-12-31","value":-221.16,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Pre-Tax Income	-	(298.51%)	26.07%	187.31%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-159.36,"profit":false},{"date":"2023-12-31","value":13.92,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income Taxes	-	(171.12%)	160.99%	449.31%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-38.08,"profit":false},{"date":"2023-12-31","value":35.83,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income After Taxes	-	(320.91%)	18.43%	154.62%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-207.55,"profit":false},{"date":"2023-12-31","value":11.92,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(320.91%)	3.86%	190.34%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-168.6,"profit":false},{"date":"2023-12-31","value":2.03,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Net Income	-	(320.91%)	18.43%	154.62%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-207.55,"profit":false},{"date":"2023-12-31","value":11.92,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

EPS (Diluted)	-	(180.19%)	229.06%	162.11%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-78.67,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":70.77,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	745.74M	747.31M	745.14M	825.41M	(2.35B)	[{"date":"2024-09-30","value":90.35,"profit":true},{"date":"2024-12-31","value":90.54,"profit":true},{"date":"2025-03-31","value":90.28,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-284.31,"profit":false}]
Cost of Revenue	188.46M	136.14M	151.56M	150.09M	(441.73M)	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":72.24,"profit":true},{"date":"2025-03-31","value":80.42,"profit":true},{"date":"2025-06-30","value":79.64,"profit":true},{"date":"2025-09-30","value":-234.39,"profit":false}]
Gross Profit	557.28M	611.17M	593.59M	675.32M	(1.90B)	[{"date":"2024-09-30","value":82.52,"profit":true},{"date":"2024-12-31","value":90.5,"profit":true},{"date":"2025-03-31","value":87.9,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-282.08,"profit":false}]
Gross Margin	74.73%	81.78%	79.66%	81.82%	81.18%	[{"date":"2024-09-30","value":91.34,"profit":true},{"date":"2024-12-31","value":99.96,"profit":true},{"date":"2025-03-31","value":97.37,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":99.22,"profit":true}]

Operating Expenses	443.39M	449.77M	369.69M	398.43M	(1.45B)	[{"date":"2024-09-30","value":98.58,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":82.2,"profit":true},{"date":"2025-06-30","value":88.59,"profit":true},{"date":"2025-09-30","value":-322.58,"profit":false}]
Operating Income	113.89M	161.41M	223.89M	276.89M	(454.09M)	[{"date":"2024-09-30","value":41.13,"profit":true},{"date":"2024-12-31","value":58.29,"profit":true},{"date":"2025-03-31","value":80.86,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-164,"profit":false}]
Total Non-Operating Income/Expense	35.63M	23.27M	30.35M	37.13M	(40.27M)	[{"date":"2024-09-30","value":95.97,"profit":true},{"date":"2024-12-31","value":62.68,"profit":true},{"date":"2025-03-31","value":81.73,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-108.46,"profit":false}]
Pre-Tax Income	134.44M	169.64M	238.09M	297.87M	(482.85M)	[{"date":"2024-09-30","value":45.13,"profit":true},{"date":"2024-12-31","value":56.95,"profit":true},{"date":"2025-03-31","value":79.93,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-162.1,"profit":false}]
Income Taxes	28.36M	44.70M	52.40M	57.34M	(114.16M)	[{"date":"2024-09-30","value":49.46,"profit":true},{"date":"2024-12-31","value":77.95,"profit":true},{"date":"2025-03-31","value":91.4,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-199.11,"profit":false}]
Income After Taxes	106.08M	124.94M	185.69M	240.53M	(368.69M)	[{"date":"2024-09-30","value":44.1,"profit":true},{"date":"2024-12-31","value":51.94,"profit":true},{"date":"2025-03-31","value":77.2,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-153.28,"profit":false}]

Income From Continuous Operations	106.08M	124.94M	185.69M	240.53M	(30.74M)	[{"date":"2024-09-30","value":44.1,"profit":true},{"date":"2024-12-31","value":51.94,"profit":true},{"date":"2025-03-31","value":77.2,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-12.78,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	106.08M	124.94M	185.69M	240.53M	(368.69M)	[{"date":"2024-09-30","value":44.1,"profit":true},{"date":"2024-12-31","value":51.94,"profit":true},{"date":"2025-03-31","value":77.2,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-153.28,"profit":false}]

EPS (Diluted)	0.55	0.92	1.13	1.44	0.12	[{"date":"2024-09-30","value":38.19,"profit":true},{"date":"2024-12-31","value":63.89,"profit":true},{"date":"2025-03-31","value":78.47,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":8.33,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Revenue	-	0.21%	(0.29%)	10.77%	(384.31%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":1.96,"profit":true},{"date":"2025-03-31","value":-2.69,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-3567.73,"profit":false}]
Cost of Revenue	-	(27.76%)	11.33%	(0.97%)	(394.31%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-245.11,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":-8.55,"profit":false},{"date":"2025-09-30","value":-3481.5,"profit":false}]
Gross Profit	-	9.67%	(2.88%)	13.77%	(382.08%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":70.23,"profit":true},{"date":"2025-03-31","value":-20.9,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-2774.87,"profit":false}]
Gross Margin	-	9.44%	(2.59%)	2.71%	(0.78%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-27.49,"profit":false},{"date":"2025-06-30","value":28.67,"profit":true},{"date":"2025-09-30","value":-8.29,"profit":false}]

Operating Expenses	-	1.44%	(17.80%)	7.77%	(464.14%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":18.5,"profit":true},{"date":"2025-03-31","value":-229.02,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-5970.67,"profit":false}]
Operating Income	-	41.72%	38.71%	23.67%	(264.00%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":92.8,"profit":true},{"date":"2025-06-30","value":56.74,"profit":true},{"date":"2025-09-30","value":-632.81,"profit":false}]
Total Non-Operating Income/Expense	-	(34.69%)	30.40%	22.35%	(208.46%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-114.11,"profit":false},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":73.52,"profit":true},{"date":"2025-09-30","value":-685.66,"profit":false}]
Pre-Tax Income	-	26.18%	40.35%	25.11%	(262.10%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":64.88,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":62.22,"profit":true},{"date":"2025-09-30","value":-649.56,"profit":false}]
Income Taxes	-	57.60%	17.24%	9.41%	(299.11%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":29.94,"profit":true},{"date":"2025-06-30","value":16.34,"profit":true},{"date":"2025-09-30","value":-519.31,"profit":false}]
Income After Taxes	-	17.78%	48.62%	29.54%	(253.28%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":36.58,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":60.75,"profit":true},{"date":"2025-09-30","value":-520.98,"profit":false}]

Income From Continuous Operations	-	17.78%	48.62%	29.54%	(112.78%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":36.58,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":60.75,"profit":true},{"date":"2025-09-30","value":-231.98,"profit":false}]
Income From Discontinued Operations	-	-	-	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Net Income	-	17.78%	48.62%	29.54%	(253.28%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":36.58,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":60.75,"profit":true},{"date":"2025-09-30","value":-520.98,"profit":false}]

EPS (Diluted)	-	67.27%	22.83%	27.43%	(91.67%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":33.93,"profit":true},{"date":"2025-06-30","value":40.78,"profit":true},{"date":"2025-09-30","value":-136.26,"profit":false}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Total Assets
Current Assets	2.27B	2.75B	2.96B	3.23B	-	[{"date":"2021-12-31","value":70.36,"profit":true},{"date":"2022-12-31","value":85.12,"profit":true},{"date":"2023-12-31","value":91.45,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Non-current Assets	3.73B	3.62B	3.89B	3.76B	-	[{"date":"2021-12-31","value":95.97,"profit":true},{"date":"2022-12-31","value":93.26,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":96.68,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Assets	6.00B	6.38B	6.84B	6.99B	-	[{"date":"2021-12-31","value":85.9,"profit":true},{"date":"2022-12-31","value":91.22,"profit":true},{"date":"2023-12-31","value":97.89,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Total Liabilities
Current Liabilities	539.82M	588.88M	1.18B	606.99M	-	[{"date":"2021-12-31","value":45.86,"profit":true},{"date":"2022-12-31","value":50.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":51.57,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Non-current Liabilities	1.19B	1.18B	713.03M	723.96M	-	[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.18,"profit":true},{"date":"2023-12-31","value":59.78,"profit":true},{"date":"2024-12-31","value":60.7,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Liabilities	1.73B	1.77B	1.89B	1.33B	-	[{"date":"2021-12-31","value":91.67,"profit":true},{"date":"2022-12-31","value":93.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":70.42,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Total Shareholders' equity
Common Stock	184.00K	186.00K	189.00K	191.00K	-	[{"date":"2021-12-31","value":96.34,"profit":true},{"date":"2022-12-31","value":97.38,"profit":true},{"date":"2023-12-31","value":98.95,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Retained Earnings	(925.69M)	(789.20M)	(621.55M)	(194.69M)	-	[{"date":"2021-12-31","value":-92568900000,"profit":false},{"date":"2022-12-31","value":-78919900000,"profit":false},{"date":"2023-12-31","value":-62155400000,"profit":false},{"date":"2024-12-31","value":-19469500000,"profit":false},{"date":"2025-12-31","value":"-","profit":true}]
Other Stockholders' Equity	5.18B	5.40B	5.60B	5.79B	-	[{"date":"2021-12-31","value":89.48,"profit":true},{"date":"2022-12-31","value":93.18,"profit":true},{"date":"2023-12-31","value":96.73,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Shareholders' equity	4.27B	4.60B	4.95B	5.66B	-	[{"date":"2021-12-31","value":75.48,"profit":true},{"date":"2022-12-31","value":81.36,"profit":true},{"date":"2023-12-31","value":87.51,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Total Liabilities & Shareholders Equity	6.00B	6.38B	6.84B	6.99B	-	[{"date":"2021-12-31","value":85.9,"profit":true},{"date":"2022-12-31","value":91.22,"profit":true},{"date":"2023-12-31","value":97.89,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25	5YR TREND
Total Assets
Current Assets	-	20.98%	7.44%	9.35%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":35.46,"profit":true},{"date":"2024-12-31","value":44.57,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Non-current Assets	-	(2.82%)	7.23%	(3.32%)	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-39.08,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-45.94,"profit":false},{"date":"2025-12-31","value":"-","profit":true}]
Total Assets	-	6.19%	7.32%	2.15%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":84.62,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":29.43,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Total Liabilities
Current Liabilities	-	9.09%	99.87%	(48.43%)	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":9.1,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-48.49,"profit":false},{"date":"2025-12-31","value":"-","profit":true}]
Non-current Liabilities	-	(0.82%)	(39.73%)	1.53%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-53.2,"profit":false},{"date":"2023-12-31","value":-2591.27,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Liabilities	-	2.27%	6.67%	(29.58%)	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":34.05,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-443.69,"profit":false},{"date":"2025-12-31","value":"-","profit":true}]

Total Shareholders' equity
Common Stock	-	1.09%	1.61%	1.06%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":67.39,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":65.61,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Retained Earnings	-	(14.74%)	(21.24%)	(68.68%)	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-12-31","value":"-","profit":true}]
Other Stockholders' Equity	-	4.13%	3.81%	3.38%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":92.19,"profit":true},{"date":"2024-12-31","value":81.67,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	7.78%	7.57%	14.27%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":54.56,"profit":true},{"date":"2023-12-31","value":53.05,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

Total Liabilities & Shareholders Equity	-	6.19%	7.32%	2.15%	-	[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":84.62,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":29.43,"profit":true},{"date":"2025-12-31","value":"-","profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	3.06B	3.23B	3.47B	3.81B	3.85B	[{"date":"2024-09-30","value":79.3,"profit":true},{"date":"2024-12-31","value":83.86,"profit":true},{"date":"2025-03-31","value":89.97,"profit":true},{"date":"2025-06-30","value":98.72,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Assets	3.79B	3.76B	3.68B	3.65B	3.76B	[{"date":"2024-09-30","value":100,"profit":true},{"date":"2024-12-31","value":99,"profit":true},{"date":"2025-03-31","value":96.96,"profit":true},{"date":"2025-06-30","value":96.22,"profit":true},{"date":"2025-09-30","value":99.1,"profit":true}]
Total Assets	6.85B	6.99B	7.15B	7.46B	7.61B	[{"date":"2024-09-30","value":89.97,"profit":true},{"date":"2024-12-31","value":91.78,"profit":true},{"date":"2025-03-31","value":93.86,"profit":true},{"date":"2025-06-30","value":97.92,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	715.66M	606.99M	628.21M	684.25M	798.44M	[{"date":"2024-09-30","value":89.63,"profit":true},{"date":"2024-12-31","value":76.02,"profit":true},{"date":"2025-03-31","value":78.68,"profit":true},{"date":"2025-06-30","value":85.7,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	722.14M	723.96M	725.34M	744.98M	759.72M	[{"date":"2024-09-30","value":95.05,"profit":true},{"date":"2024-12-31","value":95.29,"profit":true},{"date":"2025-03-31","value":95.47,"profit":true},{"date":"2025-06-30","value":98.06,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Liabilities	1.44B	1.33B	1.35B	1.43B	1.56B	[{"date":"2024-09-30","value":92.28,"profit":true},{"date":"2024-12-31","value":85.42,"profit":true},{"date":"2025-03-31","value":86.87,"profit":true},{"date":"2025-06-30","value":91.73,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	191.00K	191.00K	192.00K	192.00K	192.00K	[{"date":"2024-09-30","value":99.48,"profit":true},{"date":"2024-12-31","value":99.48,"profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Retained Earnings	(319.64M)	(194.69M)	(9.01M)	231.52M	200.78M	[{"date":"2024-09-30","value":-138.06,"profit":false},{"date":"2024-12-31","value":-84.09,"profit":false},{"date":"2025-03-31","value":-3.89,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":86.72,"profit":true}]
Other Stockholders' Equity	5.73B	5.79B	5.78B	5.84B	5.89B	[{"date":"2024-09-30","value":97.26,"profit":true},{"date":"2024-12-31","value":98.32,"profit":true},{"date":"2025-03-31","value":98.19,"profit":true},{"date":"2025-06-30","value":99.16,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Total Shareholders' equity	5.41B	5.66B	5.79B	6.03B	6.06B	[{"date":"2024-09-30","value":89.38,"profit":true},{"date":"2024-12-31","value":93.42,"profit":true},{"date":"2025-03-31","value":95.65,"profit":true},{"date":"2025-06-30","value":99.51,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	6.85B	6.99B	7.15B	7.46B	7.61B	[{"date":"2024-09-30","value":89.97,"profit":true},{"date":"2024-12-31","value":91.78,"profit":true},{"date":"2025-03-31","value":93.86,"profit":true},{"date":"2025-06-30","value":97.92,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Total Assets
Current Assets	-	5.75%	7.28%	9.73%	1.29%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":59.12,"profit":true},{"date":"2025-03-31","value":74.87,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":13.29,"profit":true}]
Non-current Assets	-	(1.00%)	(2.06%)	(0.76%)	2.99%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-33.53,"profit":false},{"date":"2025-03-31","value":-68.83,"profit":false},{"date":"2025-06-30","value":-25.5,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]
Total Assets	-	2.01%	2.26%	4.33%	2.13%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":46.45,"profit":true},{"date":"2025-03-31","value":52.25,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":49.12,"profit":true}]

Total Liabilities
Current Liabilities	-	(15.18%)	3.50%	8.92%	16.69%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-90.99,"profit":false},{"date":"2025-03-31","value":20.95,"profit":true},{"date":"2025-06-30","value":53.45,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]
Non-current Liabilities	-	0.25%	0.19%	2.71%	1.98%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":9.31,"profit":true},{"date":"2025-03-31","value":7,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":73.04,"profit":true}]
Total Liabilities	-	(7.43%)	1.70%	5.59%	9.02%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-82.38,"profit":false},{"date":"2025-03-31","value":18.82,"profit":true},{"date":"2025-06-30","value":61.98,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	0.52%	-	-	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true},{"date":"2025-06-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}]
Retained Earnings	-	(39.09%)	(95.37%)	(2669.91%)	(13.28%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]
Other Stockholders' Equity	-	1.09%	(0.13%)	0.98%	0.85%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-12.18,"profit":false},{"date":"2025-06-30","value":89.86,"profit":true},{"date":"2025-09-30","value":77.84,"profit":true}]
Total Shareholders' equity	-	4.52%	2.39%	4.03%	0.49%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":52.99,"profit":true},{"date":"2025-06-30","value":89.26,"profit":true},{"date":"2025-09-30","value":10.87,"profit":true}]

Total Liabilities & Shareholders Equity	-	2.01%	2.26%	4.33%	2.13%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":46.45,"profit":true},{"date":"2025-03-31","value":52.25,"profit":true},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":49.12,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	85.36M	304.54M	175.90M	159.26M	572.84M	[{"date":"2020-12-31","value":14.9,"profit":true},{"date":"2021-12-31","value":53.16,"profit":true},{"date":"2022-12-31","value":30.71,"profit":true},{"date":"2023-12-31","value":27.8,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	(53.62M)	(366.31M)	(20.03M)	(111.24M)	136.49M	[{"date":"2020-12-31","value":-39.29,"profit":false},{"date":"2021-12-31","value":-268.38,"profit":false},{"date":"2022-12-31","value":-14.67,"profit":false},{"date":"2023-12-31","value":-81.5,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	181.12M	(48.00K)	(18.65M)	(18.73M)	(526.45M)	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-0.03,"profit":false},{"date":"2022-12-31","value":-10.3,"profit":false},{"date":"2023-12-31","value":-10.34,"profit":false},{"date":"2024-12-31","value":-290.67,"profit":false}]

Net Change in Cash	211.71M	(61.88M)	137.25M	30.60M	187.72M	[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-29.23,"profit":false},{"date":"2022-12-31","value":64.83,"profit":true},{"date":"2023-12-31","value":14.45,"profit":true},{"date":"2024-12-31","value":88.67,"profit":true}]

Free Cash Flow
Free Cash Flow	(52.15M)	185.31M	54.94M	62.57M	475.42M	[{"date":"2020-12-31","value":-10.97,"profit":false},{"date":"2021-12-31","value":38.98,"profit":true},{"date":"2022-12-31","value":11.56,"profit":true},{"date":"2023-12-31","value":13.16,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	5YR TREND
Operating Activities
Net Operating Cash Flow	-	256.75%	(42.24%)	(9.46%)	259.69%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":98.87,"profit":true},{"date":"2022-12-31","value":-16.27,"profit":false},{"date":"2023-12-31","value":-3.64,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	583.15%	(94.53%)	455.41%	(222.70%)	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-16.21,"profit":false},{"date":"2023-12-31","value":78.1,"profit":true},{"date":"2024-12-31","value":-38.19,"profit":false}]

Financing Activities
Net Financing Cash Flow	-	(100.03%)	38754.17%	0.41%	2711.17%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-0.26,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":7,"profit":true}]

Net Change in Cash	-	(129.23%)	(321.80%)	(77.71%)	513.53%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-25.17,"profit":false},{"date":"2022-12-31","value":-62.66,"profit":false},{"date":"2023-12-31","value":-15.13,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	(455.32%)	(70.35%)	13.88%	659.85%	[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-69,"profit":false},{"date":"2022-12-31","value":-10.66,"profit":false},{"date":"2023-12-31","value":2.1,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	221.48M	185.63M	174.39M	185.27M	368.69M	[{"date":"2024-09-30","value":60.07,"profit":true},{"date":"2024-12-31","value":50.35,"profit":true},{"date":"2025-03-31","value":47.3,"profit":true},{"date":"2025-06-30","value":50.25,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	(16.16M)	76.40M	(28.24M)	(12.59M)	(330.96M)	[{"date":"2024-09-30","value":-21.15,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-36.96,"profit":false},{"date":"2025-06-30","value":-16.48,"profit":false},{"date":"2025-09-30","value":-433.17,"profit":false}]

Financing Activities
Net Financing Cash Flow	(499.13M)	2.86M	(38.78M)	(4.60M)	(2.17M)	[{"date":"2024-09-30","value":-17458.03,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":-1356.38,"profit":false},{"date":"2025-06-30","value":-161,"profit":false},{"date":"2025-09-30","value":-75.87,"profit":false}]

Net Change in Cash	(296.70M)	267.39M	105.96M	165.01M	36.29M	[{"date":"2024-09-30","value":-110.96,"profit":false},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-03-31","value":39.63,"profit":true},{"date":"2025-06-30","value":61.71,"profit":true},{"date":"2025-09-30","value":13.57,"profit":true}]

Free Cash Flow
Free Cash Flow	200.31M	165.33M	157.63M	168.17M	340.24M	[{"date":"2024-09-30","value":58.87,"profit":true},{"date":"2024-12-31","value":48.59,"profit":true},{"date":"2025-03-31","value":46.33,"profit":true},{"date":"2025-06-30","value":49.43,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	TREND
Operating Activities
Net Operating Cash Flow	-	(16.19%)	(6.05%)	6.24%	99.00%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-16.35,"profit":false},{"date":"2025-03-31","value":-6.11,"profit":false},{"date":"2025-06-30","value":6.3,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	(572.88%)	(136.96%)	(55.41%)	2528.36%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-22.66,"profit":false},{"date":"2025-03-31","value":-5.42,"profit":false},{"date":"2025-06-30","value":-2.19,"profit":false},{"date":"2025-09-30","value":100,"profit":true}]

Financing Activities
Net Financing Cash Flow	-	(100.57%)	(1456.38%)	(88.13%)	(52.88%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":null,"profit":false},{"date":"2025-03-31","value":null,"profit":false},{"date":"2025-06-30","value":null,"profit":false},{"date":"2025-09-30","value":null,"profit":false}]

Net Change in Cash	-	(190.12%)	(60.37%)	55.73%	(78.01%)	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-341.15,"profit":false},{"date":"2025-03-31","value":-108.33,"profit":false},{"date":"2025-06-30","value":100,"profit":true},{"date":"2025-09-30","value":-139.97,"profit":false}]

Free Cash Flow
Free Cash Flow	-	(17.46%)	(4.66%)	6.69%	102.32%	[{"date":"2024-09-30","value":"-","profit":true},{"date":"2024-12-31","value":-17.07,"profit":false},{"date":"2025-03-31","value":-4.55,"profit":false},{"date":"2025-06-30","value":6.54,"profit":true},{"date":"2025-09-30","value":100,"profit":true}]

Biomarin Pharmaceutical Inc Ratios

Biomarin Pharmaceutical Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

	BMRN
Cash Ratio	1.85
Current Ratio	4.83
Quick Ratio	3.10

Biomarin Pharmaceutical Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	BMRN
ROA (LTM)	6.15%
ROE (LTM)	9.07%

Biomarin Pharmaceutical Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	BMRN
Debt Ratio Lower is generally better. Negative is bad.	0.20
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	0.80

Biomarin Pharmaceutical Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	BMRN
Trailing PE	22.28
Forward PE	11.48
P/S (TTM)	3.72
P/B	1.90
Price/FCF	34
EV/R	3.44
EV/Ebitda	13.78
PEG	0.46

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Biomarin Pharmaceutical Inc share price today?

Biomarin Pharmaceutical Inc (BMRN) share price today is $59.87

Can Indians buy Biomarin Pharmaceutical Inc shares?

Yes, Indians can buy shares of Biomarin Pharmaceutical Inc (BMRN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BMRN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Biomarin Pharmaceutical Inc be purchased?

Yes, you can purchase fractional shares of Biomarin Pharmaceutical Inc (BMRN) via the Vested app. You can start investing in Biomarin Pharmaceutical Inc (BMRN) with a minimum investment of $1.

How to invest in Biomarin Pharmaceutical Inc shares from India?

You can invest in shares of Biomarin Pharmaceutical Inc (BMRN) via Vested in three simple steps:

Click on Sign Up or Invest in BMRN stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Biomarin Pharmaceutical Inc shares

What is Biomarin Pharmaceutical Inc 52-week high and low stock price?

The 52-week high price of Biomarin Pharmaceutical Inc (BMRN) is $73.51. The 52-week low price of Biomarin Pharmaceutical Inc (BMRN) is $50.76.

What is Biomarin Pharmaceutical Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Biomarin Pharmaceutical Inc (BMRN) is 22.2825

What is Biomarin Pharmaceutical Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Biomarin Pharmaceutical Inc (BMRN) is 1.90

What is Biomarin Pharmaceutical Inc dividend yield?

The dividend yield of Biomarin Pharmaceutical Inc (BMRN) is 0.00%

What is the Market Cap of Biomarin Pharmaceutical Inc?

The market capitalization of Biomarin Pharmaceutical Inc (BMRN) is $11.52B

What is Biomarin Pharmaceutical Inc's stock symbol?

The stock symbol (or ticker) of Biomarin Pharmaceutical Inc is BMRN

How Can Investors Use Biomarin Pharmaceutical Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Biomarin Pharmaceutical Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Biomarin Pharmaceutical Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Biomarin Pharmaceutical Inc shares for Indian investors?

When investing in Biomarin Pharmaceutical Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Biomarin Pharmaceutical Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Biomarin Pharmaceutical Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Biomarin Pharmaceutical Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Biomarin Pharmaceutical Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Biomarin Pharmaceutical Inc Share Price

Biomarin Pharmaceutical Inc Analyst Forecast

Biomarin Pharmaceutical Inc Share Price Chart

Biomarin Pharmaceutical Inc Key Stock Metrics

About Biomarin Pharmaceutical Inc, Common Stock

Biomarin Pharmaceutical Inc Stock Returns

Biomarin Pharmaceutical Inc Financials

Biomarin Pharmaceutical Inc Ratios

Biomarin Pharmaceutical Inc Liquidity Ratios

Biomarin Pharmaceutical Inc Asset Efficiency Ratios

Biomarin Pharmaceutical Inc Liability Ratios

Biomarin Pharmaceutical Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Company

Explore Products

Popular US Stocks ¹

Popular US ETFs ²

Curated Portfolios (Vests)

Risk Disclosure - US Markets

US Stocks & ETFs

Private Markets

Managed Portfolios (Previously Vests)

Global Funds

Global

Explore our India Diversification

INR Bonds

Alt FDs

Biomarin Pharmaceutical Inc Share Price

Biomarin Pharmaceutical Inc Analyst Forecast

Biomarin Pharmaceutical Inc Share Price Chart

Biomarin Pharmaceutical Inc Key Stock Metrics

About Biomarin Pharmaceutical Inc, Common Stock

Biomarin Pharmaceutical Inc Stock Returns

Biomarin Pharmaceutical Inc Financials

Biomarin Pharmaceutical Inc Ratios

Biomarin Pharmaceutical Inc Liquidity Ratios

Biomarin Pharmaceutical Inc Asset Efficiency Ratios

Biomarin Pharmaceutical Inc Liability Ratios

Biomarin Pharmaceutical Inc Valuation Ratios

Discover more

FAQs

Feedback

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

Popular US Stocks ¹

Popular US ETFs ²